GURUFOCUS.COM » STOCK LIST » Basic Materials » Chemicals » Infinium Pharmachem Ltd (NSE:INFINIUM) » Definitions » ROC %

Infinium Pharmachem (NSE:INFINIUM) ROC % : 12.20% (As of Sep. 2024)


View and export this data going back to 2023. Start your Free Trial

What is Infinium Pharmachem ROC %?

ROC % measures how well a company generates cash flow relative to the capital it has invested in its business. It is also called ROIC %. Infinium Pharmachem's annualized return on capital (ROC %) for the quarter that ended in Sep. 2024 was 12.20%.

As of today (2025-04-07), Infinium Pharmachem's WACC % is 12.84%. Infinium Pharmachem's ROC % is 12.77% (calculated using TTM income statement data). Infinium Pharmachem earns returns that do not match up to its cost of capital. It will destroy value as it grows.


Infinium Pharmachem ROC % Historical Data

The historical data trend for Infinium Pharmachem's ROC % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Infinium Pharmachem ROC % Chart

Infinium Pharmachem Annual Data
Trend Mar20 Mar21 Mar22 Mar23 Mar24
ROC %
10.20 19.49 25.60 24.35 20.32

Infinium Pharmachem Semi-Annual Data
Mar20 Mar21 Mar22 Sep22 Mar23 Sep23 Mar24 Sep24
ROC % Get a 7-Day Free Trial 28.53 18.46 21.16 15.02 12.20

Infinium Pharmachem ROC % Calculation

Infinium Pharmachem's annualized Return on Capital (ROC %) for the fiscal year that ended in Mar. 2024 is calculated as:

ROC % (A: Mar. 2024 )
=NOPAT/Average Invested Capital
=Operating Income * ( 1 - Tax Rate % )/( (Invested Capital (A: Mar. 2023 ) + Invested Capital (A: Mar. 2024 ))/ count )
=159.657 * ( 1 - 24.37% )/( (541.341 + 647.259)/ 2 )
=120.7485891/594.3
=20.32 %

where

Invested Capital(A: Mar. 2023 )
=Total Assets - Accounts Payable & Accrued Expense - Excess Cash
=Total Assets - Accounts Payable & Accrued Expense - ( Cash, Cash Equivalents, Marketable Securities - max(0, Total Current Liabilities - Total Current Assets+Cash, Cash Equivalents, Marketable Securities))
=706.122 - 104.986 - ( 59.795 - max(0, 367.691 - 513.131+59.795))
=541.341

Invested Capital(A: Mar. 2024 )
=Total Assets - Accounts Payable & Accrued Expense - Excess Cash
=Total Assets - Accounts Payable & Accrued Expense - ( Cash, Cash Equivalents, Marketable Securities - max(0, Total Current Liabilities - Total Current Assets+Cash, Cash Equivalents, Marketable Securities))
=854.527 - 88.154 - ( 119.114 - max(0, 174.135 - 650.112+119.114))
=647.259

Infinium Pharmachem's annualized Return on Capital (ROC %) for the quarter that ended in Sep. 2024 is calculated as:

ROC % (Q: Sep. 2024 )
=NOPAT/Average Invested Capital
=Operating Income * ( 1 - Tax Rate % )/( (Invested Capital (Q: Mar. 2024 ) + Invested Capital (Q: Sep. 2024 ))/ count )
=139.268 * ( 1 - 25.35% )/( (647.259 + 1056.406)/ 2 )
=103.963562/851.8325
=12.20 %

where

Invested Capital(Q: Mar. 2024 )
=Total Assets - Accounts Payable & Accrued Expense - Excess Cash
=Total Assets - Accounts Payable & Accrued Expense - ( Cash, Cash Equivalents, Marketable Securities - max(0, Total Current Liabilities - Total Current Assets+Cash, Cash Equivalents, Marketable Securities))
=854.527 - 88.154 - ( 119.114 - max(0, 174.135 - 650.112+119.114))
=647.259

Invested Capital(Q: Sep. 2024 )
=Total Assets - Accounts Payable & Accrued Expense - Excess Cash
=Total Assets - Accounts Payable & Accrued Expense - ( Cash, Cash Equivalents, Marketable Securities - max(0, Total Current Liabilities - Total Current Assets+Cash, Cash Equivalents, Marketable Securities))
=1338.549 - 124.626 - ( 157.517 - max(0, 300.093 - 696.635+157.517))
=1056.406

Note: The Operating Income data used here is two times the semi-annual (Sep. 2024) data.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Infinium Pharmachem  (NSE:INFINIUM) ROC % Explanation

ROC % measures how well a company generates cash flow relative to the capital it has invested in its business. It is also called ROIC %. The reason book values of debt and equity are used is because the book values are the capital the company received when issuing the debt or receiving the equity investments.

There are four key components to this definition. The first is the use of operating income or EBIT rather than net income in the numerator. The second is the tax adjustment to this operating income or EBIT, computed as a hypothetical tax based on an effective or marginal tax rate. The third is the use of book values for invested capital, rather than market values. The final is the timing difference; the capital invested is from the end of the prior year whereas the operating income or EBIT is the current year's number.

Why is ROC % important?

Because it costs money to raise capital. A firm that generates higher returns on investment than it costs the company to raise the capital needed for that investment is earning excess returns. A firm that expects to continue generating positive excess returns on new investments in the future will see its value increase as growth increases, whereas a firm that earns returns that do not match up to its cost of capital will destroy value as it grows.

As of today, Infinium Pharmachem's WACC % is 12.84%. Infinium Pharmachem's ROC % is 12.77% (calculated using TTM income statement data). Infinium Pharmachem earns returns that do not match up to its cost of capital. It will destroy value as it grows.


Be Aware

Like ROE % and ROA %, ROC % is calculated with only 12 months of data. Fluctuations in the company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective.


Infinium Pharmachem ROC % Related Terms

Thank you for viewing the detailed overview of Infinium Pharmachem's ROC % provided by GuruFocus.com. Please click on the following links to see related term pages.


Infinium Pharmachem Business Description

Traded in Other Exchanges
N/A
Address
V.U. Nagar GIDC Road, Near Sardar Patel Statue, Suite 205, Sigma Prime, 2nd Floor, District Anand, Vallabh Vidhyanagar, GJ, IND, 388120
Infinium Pharmachem Ltd is engaged in the business of manufacturing and supplying Iodine, Iodine Derivatives and Active Pharmaceutical Ingredients (APIs). It provides fully integrated customized services from R & D to Commercial scale manufacturing and packaging for its products to the Pharmaceutical, Agrochemical, Nutraceutical, Speciality Chemicals and various other chemicals Industries.

Infinium Pharmachem Headlines

No Headlines